Hepion Pharmaceuticals, Inc. (HEPA) Insider Trading
3 insider purchases in the last 7 days
| INSIDER | DATE | SHARES | PRICE | TOTAL VALUE | OWNED AFTER |
|---|---|---|---|---|---|
| LoPriore Vincent S Executive Chairman | Apr 21, 2026 | 5,000,000 | $0.04 | $200K | 5,000,000 |
| Stetz Gary S. CEO | Apr 21, 2026 | 1,250,000 | $0.04 | $50K | 1,250,000 |
| Appajosyula Sireesh Director | Apr 21, 2026 | 1,250,000 | $0.04 | $50K | 1,250,000 |
Want more?
Sign up free to see 30+ days of history, set alerts, and track HEPA on your watchlist.
Start for FreeAbout Hepion Pharmaceuticals, Inc. Insider Trading
3 insiders at Hepion Pharmaceuticals, Inc. (HEPA) have purchased stock in the past 90 days, totaling $300K across 3 transactions (7,500,000 shares).
The most recent purchase was by Executive Chairman LoPriore Vincent S on April 21, 2026 — a $200K buy of 5,000,000 shares at $0.04, bringing his total holdings to 5,000,000 shares.
Insiders who purchased: LoPriore Vincent S (Executive Chairman, 1 buy totaling $200K); Stetz Gary S. (CEO, 1 buy totaling $50K); Appajosyula Sireesh (Director, 1 buy totaling $50K).
This insider buying is notable given that HEPA had no recorded open market purchases in the nine months before that.
With 3 different insiders buying in the same 90-day window, this qualifies as cluster buying at HEPA — a pattern that research suggests can signal conviction among management.
Track HEPA insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.